Continuous palliative sedation in hospices and palliative care units in nursing homes

Continuous palliative sedation in hospices and palliative care units in nursing homes - palliative sedation

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON34311

Enrollment

774

Registered

2010-12-28

Start date

2011-03-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

alle aandoeningen bij patienten opgenomen in het hospice of palliatief geoormerkte bedden van het verpleeghuis nvt

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - admission to hospice of palliative care unit in nursing home - informed consent

Exclusion criteria

Exclusion criteria: - no signed informed consent form - not deceased patients at the end of the inclusion period - patients being discharged

Design outcomes

Primary

Measure	Time frame
From all newly admitted patients the following information will be documented: age, sex, functional status according to the Karnofsky Performance Status Scale, symptoms according to the Edmonton Symptom Assessment Scale, diagnoses classified with the tenth edition Dutch version of the International Statistical Classification of Diseases and Related Health Problem, level of communication ability/level of conscience according the Glasgow Coma Scale (GCS) and medication at time of admission classified according to the Anatomically Therapeutic Chemical (ATC) code system. This information will be considered as the independent variables when analyzing the predisposing factors. Patients will be tracked until they will or will not be treated with CPS. From the patients who will be treated with CPS, the following information will be collected with pre-formulated questions: the initiator of the conversation to administer CPS, possible conducted consultation before starting CPS, possible conducted use of intermittent sedation, the (in)existence of an previous euthanasia request and the reason of not granting the request, the presence of informed consent from the patient and/or his/her representative to administer CPS, the indication of CPS, the goal of CPS and the life expectancy before the start of CPS. After the patient deceased there will be research as to the possibility of a shorter duration of CPS and the effectiveness of CPS according to the physician. From the start of CPS application there will be information documented about the intake through a fluid-list, the duration of the CPS, the medication use classified according to the ATC code system and the course of the conscience level through the GCS.	—

Measure

Time frame

From all newly admitted patients the following information will be documented: age, sex, functional status according to the Karnofsky Performance Status Scale, symptoms according to the Edmonton Symptom Assessment Scale, diagnoses classified with the tenth edition Dutch version of the International Statistical Classification of Diseases and Related Health Problem, level of communication ability/level of conscience according the Glasgow Coma Scale (GCS) and medication at time of admission classified according to the Anatomically Therapeutic Chemical (ATC) code system. This information will be considered as the independent variables when analyzing the predisposing factors. Patients will be tracked until they will or will not be treated with CPS. From the patients who will be treated with CPS, the following information will be collected with pre-formulated questions: the initiator of the conversation to administer CPS, possible conducted consultation before starting CPS, possible conducted use of intermittent sedation, the (in)existence of an previous euthanasia request and the reason of not granting the request, the presence of informed consent from the patient and/or his/her representative to administer CPS, the indication of CPS, the goal of CPS and the life expectancy before the start of CPS. After the patient deceased there will be research as to the possibility of a shorter duration of CPS and the effectiveness of CPS according to the physician. From the start of CPS application there will be information documented about the intake through a fluid-list, the duration of the CPS, the medication use classified according to the ATC code system and the course of the conscience level through the GCS.

—

Secondary

Measure	Time frame
In all patientes, date of admission and death wil be collected. From the patients who will be treated with CPS, there will be information documented of the course of the comfort levels with the Discomfort Scale-Dementia of Alzheimer Type.	—

Countries

Netherlands

Outcome results